Stock performance

Curaleaf Holdings (CURA) (CURLF) has started 2019 on a stronger note. As of April 9, the company’s stock price has increased 83.0% since the beginning of the year. In comparison, the Horizons Marijuana Life Sciences ETF (HMMJ), which tracks the performance of the public-listed cannabis business in North American, has returned 45.9%, while the ETFMG Alternative Harvest ETF (MJ) has returned 41.4%.

Curaleaf has also outperformed its peers including MedMen Enterprises (MMEN) (MMNFF) and Acreage Holdings (ACRG-U) (ACRGF), which have returned -1.0% and 4.2% YTD (year-to-date), respectively.

Is There More Upside to Curaleaf Holdings’ Stock Price?

Sign up for Bagels & Stox, our witty take on the top market and investment news, straight to your inbox! Whether you’re a serious investor or just want to be informed, Bagels & Stox will be your favorite email.

Drivers of Curaleaf’s stock price

On March 20, during its fourth-quarter earnings call, Curaleaf’s management announced that CVS Health (CVS) would sell its CBD products in over 800 CVS stores. CVS, which operates more than 10,000 drugstores, stated that it will offer CBD creams, sprays, and lotions. CVS won’t be selling any supplements or food additives that contain CBD.

Curaleaf completed the acquisition of Eureka. The company also signed an agreement to acquire Acres Cannabis for $70 million. Eureka is a California-based company. Eureka operates a cultivation facility and is developing three dispensaries. Acres Cannabis operates 269,000 square feet of cultivation facilities and a cannabis dispensary in Las Vegas, Nevada. The acquisitions are expected to strengthen Curaleaf’s posting in California and Nevada. Along with these announcements, the stronger broader equity market led to a rise in Curaleaf’s stock price.

Latest articles

Broadcom (AVGO) stock fell ~8.5% after markets closed yesterday following the semiconductor giant's fiscal 2019 second-quarter earnings release. It missed analysts' revenue estimate and cut its fiscal 2019 revenue guidance by $2 billion to $22.5 billion due to sluggishness in its semiconductor solutions business.

The SPDR Gold Shares ETF (GLD), which tracks physical gold prices, has underperformed the broader markets year-to-date, rising just 4.4% compared to the S&P 500’s (SPY) gain of 15.9% as of June 14. The sentiment for gold, however, has been turning around.

Safe havens such as Treasuries and gold were back in favor on June 14 as stocks fell due to rising tensions in the Middle East, concerns over growth, and the looming threat of the US-China trade war. The tech-heavy Nasdaq Composite Index fell 0.67% in the first hour of trading.

Lululemon (LULU) stock rose 2.1% on June 13 in reaction to better-than-expected first-quarter results and an upgraded outlook for fiscal 2019 overall. The company's first-quarter adjusted EPS grew 34.5% to $0.74 on revenue growth of 20.4% to $782.32 million. Analysts had expected EPS of $0.70 and revenue of $755.31 million. Here's why the outlook got an upgrade.

14 Jun

IEA Again Slashes Its Oil Demand Growth Estimate

WRITTEN BY Rabindra Samanta

As of 4:40 AM Eastern Time today, US crude oil active futures were at $51.83, ~4% below their closing level in the previous week. If US crude oil prices stay at those levels today, they'll mark their third week of decline in five weeks.

14 Jun

Why Kimberly-Clark Stock May Stop Rising


Kimberly-Clark (KMB) stock has risen 20.5% this year, boosted by the company’s better-than-expected sales and earnings during its last reported quarter. However, its stock could stop climbing. Here's why.